SCHEDULE 13G/A: Morgan Stanley Discloses 7.3% Stake in Guggenheim Active Allocation Fund

Sentiment:

Beneficial Ownership Report


Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have disclosed a 7.3% beneficial ownership stake in Guggenheim Active Allocation Fund as of December 31, 2024.

Summary

  • Morgan Stanley and its wholly-owned subsidiary, Morgan Stanley Smith Barney LLC, jointly reported beneficial ownership of 2,410,013 common shares of Guggenheim Active Allocation Fund.
  • This ownership represents 7.3% of the total class of securities.
  • The filing is an Amendment No. 2 to a Schedule 13G, indicating an update to a previously reported stake.
  • The reporting persons hold shared voting power over 1.00 share and shared dispositive power over 2,410,013.00 shares.
  • The filing certifies that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: Neutral, as this is a factual regulatory disclosure of beneficial ownership with no explicit positive or negative operational or financial news.

Positives

  • The disclosure of a significant institutional holding by Morgan Stanley indicates a notable investment in Guggenheim Active Allocation Fund, potentially signaling confidence in the fund's strategy or underlying assets.

Negatives

  • No specific negative information regarding the issuer's financial performance or operational challenges is disclosed in this beneficial ownership report.

Risks

  • This beneficial ownership report does not contain specific risks related to the issuer's operations, financial health, or strategic outlook. It is solely a disclosure of ownership.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's future performance or strategic outlook.

Management Comments

  • The filing includes a certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Industry Context

This Schedule 13G filing reflects a standard regulatory disclosure by a major financial institution, Morgan Stanley, regarding its significant passive investment in an investment fund, Guggenheim Active Allocation Fund. Such filings are routine for institutional investors holding more than 5% of a company's shares, providing transparency on large ownership stakes within the financial services and asset management sectors.

Comparison to Industry Standards

  • As a Schedule 13G filing, this document primarily serves as a regulatory disclosure of beneficial ownership and does not provide financial results or operational data for direct comparison to industry benchmarks or specific comparable companies/projects.
  • The 7.3% stake held by Morgan Stanley is a significant institutional position, common among large asset managers and investment banks holding passive stakes in various funds and companies, aligning with typical institutional investment patterns.

Related Party Transactions

  • The filing explicitly states that the securities being reported on by Morgan Stanley as a parent holding company are owned, or may be deemed to be beneficially owned, by Morgan Stanley Smith Barney LLC, a wholly-owned subsidiary of Morgan Stanley, detailing an intra-group relationship.

Stakeholder Impact

  • Shareholders of Guggenheim Active Allocation Fund gain transparency regarding a significant institutional holder and the size of its stake.
  • Morgan Stanley's clients whose assets are managed by Morgan Stanley Smith Barney LLC are indirectly impacted by the fund's performance.

Next Steps

  • The reporting persons will continue to comply with SEC regulations regarding beneficial ownership disclosures, filing amendments as required by changes in their holdings.

Key Dates

DateDescription
12/31/2024Date of event which requires filing of this statement (end of reporting period).
02/04/2025Date of filing of the Schedule 13G Amendment No. 2.

Keywords

Morgan Stanley, Guggenheim Active Allocation Fund, SEC filing, Schedule 13G, beneficial ownership, institutional investment, common shares, investment fund, asset management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.